Population-scale genomics hospitals can trust
Genomics
End-to-end genomics platforms — from sample ingestion to variant interpretation — built for governance, interoperability, and clinical-grade quality control at national-programme scale.
Delivered AI-native — lean, fast, compliant and cost-effective. No AI coating, no legacy bloat, no year-long rollouts.
Capabilities
What we deliver
Germline and somatic analysis at population scale
FHIR Genomics integration with EHR systems
Pharmacogenomics and polygenic risk scoring
Rare disease and oncology interpretation workflows
Consent, governance and data-sovereignty frameworks
Reference panel management and QC automation
Our targets
The bar we hold ourselves to on every engagement — and report against, honestly.
End-to-end
support from sample ingestion to clinical interpretation
72h
clinical-grade turnaround for urgent panels
99.9%
concordance against reference benchmarks